Neutrons reveal potential dangers of gold nanoparticles—pharma's drug delivery agent of the future

Scientists working at the Institut Laue-Langevin have shown that the charge of gold nanoparticles, identified by major pharmaceutical companies as a drug delivery agent of the future for the treatment of cancer, affects how they interact with our cell's protective outer wall. These crucial insights, published in Langmuir, provide a first step in the effective design of safe nanoparticles for biomedical applications and the practices and procedures for their secure handling in a variety of other consumer products.

Read the whole article on Physorg

More from Physorg